The Board of Directors of the Company at their meeting held today i.e. November 14, 2025, inter alia, duly approved and took on record the Unaudited Standalone Financial Results for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Broach Lifecare Hospital's revenue from operations grew strongly to Rs 260.42 lakhs in H1 FY26 (ended Sep 30, 2025), up about 44% from Rs 180.84 lakhs in H1 FY25. However, profit after tax fell roughly 29% to Rs 31.21 lakhs (from Rs 44.19 lakhs), as total expenses surged over 82% — driven by higher employee costs and a sharp jump in 'other expenses'. EPS slipped to Rs 1.03 from Rs 1.70. Operating cash flow remained deeply negative at Rs -157.23 lakhs (vs Rs -62.18 lakhs prior), reflecting working capital strain. The company confirmed no deviation in use of IPO proceeds (raised Aug 2024, Rs 402 lakhs) and appointed M/s. R.M. Hariyani & Co as Internal Auditor and M/s. NR Shah & Co as Secretarial Auditor for FY25-26. Statutory auditor K.K. Haryani & Co issued an unmodified limited review report.
Mixed picture for shareholders — strong top-line growth is encouraging but profitability is shrinking on rising costs and weak cash generation; the stock could see pressure until margins and cash flow improve.